Literature DB >> 31612388

Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B.

Semvua Bukheti Kilonzo1, Yong-Li Wang1, Qun-Qun Jiang1, Wen-Yu Wu1, Peng Wang1, Qin Ning2, Mei-Fang Han3.   

Abstract

Hepatitis E virus (HEV) infection is a major cause of morbidity in endemic areas. Its consequences among chronic hepatitis B (CHB) patients have been under-reported. The aim of this study was to assess the impact of superinfective HEV infection (acute and past) on virological and clinical features of patients with CHB infection. Clinical, biochemical, virological and immunological data of 153 CHB patients including 98 with hepatitis B virus (HBV) monoinfection and 55 with HBV-HEV superinfection with both HEV and HBV infection was retrospectively investigated and analyzed in this study conducted in Wuhan, China. An overall anti-HEV IgG seroprevalence was found to be 35.9% in CHB patients. HBV-HEV superinfection patients showed significantly higher rate of complications (ascites, hepato-renal syndrome & encephalopathy) (all with P=0.04), cirrhosis (P<0.001) and acute-on-chronic liver failure (P<0.001) than HBV monoinfection patients. They also displayed elevated ALTs (P<0.001) and total serum bilirubin (P<0.001) with diminished albumin (P<0.001) and HBV viral load (P<0.001). Cytokines assay revealed increased expression of IL-6 (P=0.02), IL-10 (P=0.009) and TNF-α (P=0.003) in HBV-HEV superinfection patients compared to HBV monoinfection patients. Our study demonstrated that HEV superinfection in CHB patients was associated with progressive clinical manifestation, which is likely due to the enhanced expression of cytokines related with hepatocytes necrosis. HEV was also associated with repressed HBV replication, but the underlying mechanism requires further investigation.

Entities:  

Keywords:  hepatitis B; hepatitis E; liver failure; replication; superinfection

Mesh:

Substances:

Year:  2019        PMID: 31612388     DOI: 10.1007/s11596-019-2097-0

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  24 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

2.  [A study of chronic hepatitis B infection superinfected with hepatitis E infection].

Authors:  Guo-Shun Zhang; Fu-Min Feng; Yu-Lin Li; Ju-Xiang Yuan; Hua Shang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2006-12

3.  Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.

Authors:  Henry Lik-Yuen Chan; Steven Woon-Choi Tsang; Chook-Tiew Liew; Chi-Hang Tse; May-Ling Wong; Jessica Yuet-ling Ching; Nancy Wai-Yee Leung; John Siu-Lun Tam; Joseph Jao-Yiu Sung
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

4.  Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death.

Authors:  Subrat Kumar Acharya; Praveen Kumar Sharma; Rajbir Singh; Sujit Kumar Mohanty; Kaushal Madan; Jyotish Kumar Jha; Subrat Kumar Panda
Journal:  J Hepatol       Date:  2006-11-03       Impact factor: 25.083

5.  Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B.

Authors:  Xiaohong Zhang; Weimin Ke; Junqiang Xie; Zhixin Zhao; Dongying Xie; Zhiliang Gao
Journal:  Hepatol Int       Date:  2010-08-01       Impact factor: 6.047

Review 6.  Hepatitis E virus: Current epidemiology and vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Xiaotian Hao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

7.  Clinical analysis of patients suffering from chronic hepatitis B superinfected with other hepadnaviruses.

Authors:  Jia Fu; Dan Guo; Dandan Gao; Wenxiang Huang; Ziqiong Li; Bei Jia
Journal:  J Med Virol       Date:  2015-11-18       Impact factor: 2.327

Review 8.  Macrophage cytokines: involvement in immunity and infectious diseases.

Authors:  Guillermo Arango Duque; Albert Descoteaux
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

9.  Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.

Authors:  Li Zhang; Zechun Jiang; Jingjing Lv; Jiaye Liu; Bingyu Yan; Yi Feng; Li Li; Guomin Zhang; Fuzhen Wang; Aiqiang Xu
Journal:  BMC Infect Dis       Date:  2018-02-12       Impact factor: 3.090

10.  Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report.

Authors:  Chau-Ting Yeh; Christopher Sung-Huan Yeh; Yu-De Chu; Yang-Jen Chiang
Journal:  J Med Case Rep       Date:  2018-02-28
View more
  1 in total

1.  Serological Evidence of Hepatitis B and E and Dengue Coinfection in Chadian Patients and Impact on Lipidemia Profile.

Authors:  Alexandre Kanga Djasrabe; Borris Rosnay Tietcheu Galani; Moussa Mahamat Ali; Fissou Henry Yandai; Bessimbaye Nadlaou; Mayann Habkreo; Nicolas Yanou Njintang
Journal:  Int J Hepatol       Date:  2022-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.